SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 5,304 Shares

SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari sold 5,304 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total transaction of $73,778.64. Following the completion of the transaction, the chief financial officer now owns 189,319 shares in the company, valued at approximately $2,633,427.29. The trade was a 2.73 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Anshul Maheshwari also recently made the following trade(s):

• On Monday, November 18th, Anshul Maheshwari sold 2,439 shares of SI-BONE stock. The shares were sold at an average price of $12.68, for a total value of $30,926.52.

SI-BONE Trading Down 1.1 %

Shares of SI-BONE stock traded down $0.15 during trading on Monday, hitting $14.12. The stock had a trading volume of 231,586 shares, compared to its average volume of 251,762. SI-BONE, Inc. has a 12 month low of $11.70 and a 12 month high of $21.64. The firm’s fifty day simple moving average is $13.58 and its 200-day simple moving average is $14.14. The stock has a market cap of $592.16 million, a PE ratio of -15.35 and a beta of 1.16. The company has a debt-to-equity ratio of 0.22, a current ratio of 8.25 and a quick ratio of 7.22.

Institutional Investors Weigh In On SI-BONE

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Harbor Capital Advisors Inc. boosted its stake in shares of SI-BONE by 222.5% in the third quarter. Harbor Capital Advisors Inc. now owns 620,490 shares of the company’s stock worth $8,674,000 after buying an additional 428,110 shares during the last quarter. American Century Companies Inc. grew its position in SI-BONE by 22.8% in the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock worth $25,685,000 after acquiring an additional 368,637 shares during the period. Champlain Investment Partners LLC increased its holdings in SI-BONE by 14.7% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock valued at $39,145,000 after purchasing an additional 358,821 shares during the last quarter. Paradigm Capital Management Inc. NY lifted its position in shares of SI-BONE by 24.7% during the second quarter. Paradigm Capital Management Inc. NY now owns 1,349,400 shares of the company’s stock worth $17,448,000 after purchasing an additional 267,100 shares in the last quarter. Finally, Impax Asset Management Group plc increased its holdings in SI-BONE by 41.3% during the 3rd quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock worth $10,604,000 after purchasing an additional 221,604 shares during the period. Hedge funds and other institutional investors own 98.11% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on SIBN shares. Needham & Company LLC reissued a “buy” rating and issued a $19.00 price target on shares of SI-BONE in a research report on Wednesday, November 20th. Truist Financial raised their price target on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $23.00.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.